/stockhouse.com/companies/quote?symbol=c.cbii" style="box-sizing: inherit; outline: 0px">CSE:CBII,Forum) stated this week that it will take over patient care for one of New Jersey’s largest medical cannabis evaluation and education clinic groups, New Jersey Alternative Medicine, on July 1st, 2019.
For more on this latest acquisition, click here.
A provider of predictive analytics tools, data-driven software and comprehensive services across the cannabis value chain, CB2 recently announced its next shareholder meetingscheduled for June 27th, 2019 at 10am EST at its head office at 5045 Orbitor Drive, Mississauga, ON.
FULL DISCLOSURE: CB2 Insights Inc. is a client of Stockhouse Publishing.